Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.
Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD, Leming PD, Lipson EJ, Puzanov I, Smith DC, Taube JM, Wigginton JM, Kollia GD, Gupta A, Pardoll DM, Sosman JA, Hodi FS.
Topalian SL, et al. Among authors: sznol m.
J Clin Oncol. 2023 Feb 10;41(5):943-954. doi: 10.1200/JCO.22.02272.
J Clin Oncol. 2023.
PMID: 36750016
Clinical Trial.